Amy B. Vanatta

Array ( [id] => 1358065 [patent_doc_number] => 06576785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-06-10 [patent_title] => '-cycloalkyl-prostaglandin E2 derivatives' [patent_app_type] => B1 [patent_app_number] => 09/570728 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25942 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 245 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/576/06576785.pdf [firstpage_image] =>[orig_patent_app_number] => 09570728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1565849 [patent_doc_number] => 06339160 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Metalloproteinase inhibitors, their therapeutic use and process for the production of the starting compound in the synthesis thereof' [patent_app_type] => B1 [patent_app_number] => 09/462932 [patent_app_country] => US [patent_app_date] => 2000-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11020 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/339/06339160.pdf [firstpage_image] =>[orig_patent_app_number] => 09462932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4385700 [patent_doc_number] => 06277996 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Thiazole compound and a process thereof' [patent_app_type] => 1 [patent_app_number] => 9/564979 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3349 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277996.pdf [firstpage_image] =>[orig_patent_app_number] => 564979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410225 [patent_doc_number] => 06310088 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity' [patent_app_type] => 1 [patent_app_number] => 9/564217 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5419 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 731 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/310/06310088.pdf [firstpage_image] =>[orig_patent_app_number] => 564217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7643814 [patent_doc_number] => 06429226 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-06 [patent_title] => 'Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension' [patent_app_type] => B1 [patent_app_number] => 09/562447 [patent_app_country] => US [patent_app_date] => 2000-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7899 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/429/06429226.pdf [firstpage_image] =>[orig_patent_app_number] => 09562447 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1586323 [patent_doc_number] => 06358983 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Heterocyclically substituted -hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor antagonists' [patent_app_type] => B1 [patent_app_number] => 09/530382 [patent_app_country] => US [patent_app_date] => 2000-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16440 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 751 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358983.pdf [firstpage_image] =>[orig_patent_app_number] => 09530382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414982 [patent_doc_number] => 06525081 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Antirheumatic' [patent_app_type] => B1 [patent_app_number] => 09/530082 [patent_app_country] => US [patent_app_date] => 2000-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21500 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 186 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/525/06525081.pdf [firstpage_image] =>[orig_patent_app_number] => 09530082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1291943 [patent_doc_number] => 06630506 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-07 [patent_title] => 'Bicyclic acyl guanidine sodium/proton exchange inhibitors and method' [patent_app_type] => B1 [patent_app_number] => 09/556739 [patent_app_country] => US [patent_app_date] => 2000-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6535 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/630/06630506.pdf [firstpage_image] =>[orig_patent_app_number] => 09556739 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4368682 [patent_doc_number] => 06274608 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Compounds, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 9/551700 [patent_app_country] => US [patent_app_date] => 2000-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7804 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274608.pdf [firstpage_image] =>[orig_patent_app_number] => 551700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1333675 [patent_doc_number] => 06596746 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-22 [patent_title] => 'Cyclic protein tyrosine kinase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/548929 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33557 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/596/06596746.pdf [firstpage_image] =>[orig_patent_app_number] => 09548929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274484 [patent_doc_number] => 06245927 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Process for the preparation of 2-chloro-5-chloromethyl-1,3-thiazole' [patent_app_type] => 1 [patent_app_number] => 9/547221 [patent_app_country] => US [patent_app_date] => 2000-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7109 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245927.pdf [firstpage_image] =>[orig_patent_app_number] => 547221 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1454694 [patent_doc_number] => 06462198 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Carbamic acid derivatives' [patent_app_type] => B1 [patent_app_number] => 09/545622 [patent_app_country] => US [patent_app_date] => 2000-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8880 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462198.pdf [firstpage_image] =>[orig_patent_app_number] => 09545622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4251997 [patent_doc_number] => 06222057 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Process for the preparation of 2-chloro-5-chloromethyl-1,3-thiazole' [patent_app_type] => 1 [patent_app_number] => 9/545349 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7111 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/222/06222057.pdf [firstpage_image] =>[orig_patent_app_number] => 545349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416859 [patent_doc_number] => 06521650 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-18 [patent_title] => 'Amines as pharmaceutical agents' [patent_app_type] => B1 [patent_app_number] => 09/509917 [patent_app_country] => US [patent_app_date] => 2000-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7791 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/521/06521650.pdf [firstpage_image] =>[orig_patent_app_number] => 09509917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636226 [patent_doc_number] => 06380434 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Fullerene derivatives' [patent_app_type] => B1 [patent_app_number] => 09/541337 [patent_app_country] => US [patent_app_date] => 2000-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9491 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380434.pdf [firstpage_image] =>[orig_patent_app_number] => 09541337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1418111 [patent_doc_number] => 06518289 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => '1-substituted-1-aminomethyl-cycloalkane derivatives (gabapentin analogues), their preparation and their use in the treatment of neurological disorders' [patent_app_type] => B1 [patent_app_number] => 09/509905 [patent_app_country] => US [patent_app_date] => 2000-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11626 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518289.pdf [firstpage_image] =>[orig_patent_app_number] => 09509905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4296074 [patent_doc_number] => 06197800 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists' [patent_app_type] => 1 [patent_app_number] => 9/463311 [patent_app_country] => US [patent_app_date] => 2000-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3871 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197800.pdf [firstpage_image] =>[orig_patent_app_number] => 463311 [rel_patent_id] =>[rel_patent_doc_number] =>)